These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29803967)

  • 1. Induced pluripotent stem cells derived from a schizophrenia patient with ASTN2 deletion.
    Arioka Y; Kushima I; Kubo H; Mori D; Ozaki N
    Stem Cell Res; 2018 Jul; 30():81-84. PubMed ID: 29803967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes.
    Lionel AC; Tammimies K; Vaags AK; Rosenfeld JA; Ahn JW; Merico D; Noor A; Runke CK; Pillalamarri VK; Carter MT; Gazzellone MJ; Thiruvahindrapuram B; Fagerberg C; Laulund LW; Pellecchia G; Lamoureux S; Deshpande C; Clayton-Smith J; White AC; Leather S; Trounce J; Melanie Bedford H; Hatchwell E; Eis PS; Yuen RK; Walker S; Uddin M; Geraghty MT; Nikkel SM; Tomiak EM; Fernandez BA; Soreni N; Crosbie J; Arnold PD; Schachar RJ; Roberts W; Paterson AD; So J; Szatmari P; Chrysler C; Woodbury-Smith M; Brian Lowry R; Zwaigenbaum L; Mandyam D; Wei J; Macdonald JR; Howe JL; Nalpathamkalam T; Wang Z; Tolson D; Cobb DS; Wilks TM; Sorensen MJ; Bader PI; An Y; Wu BL; Musumeci SA; Romano C; Postorivo D; Nardone AM; Monica MD; Scarano G; Zoccante L; Novara F; Zuffardi O; Ciccone R; Antona V; Carella M; Zelante L; Cavalli P; Poggiani C; Cavallari U; Argiropoulos B; Chernos J; Brasch-Andersen C; Speevak M; Fichera M; Ogilvie CM; Shen Y; Hodge JC; Talkowski ME; Stavropoulos DJ; Marshall CR; Scherer SW
    Hum Mol Genet; 2014 May; 23(10):2752-68. PubMed ID: 24381304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three lines of induced pluripotent stem cells derived from a 15q11.2-q13.1 duplication syndrome patient.
    Arioka Y; Kushima I; Mori D; Ozaki N
    Stem Cell Res; 2018 Aug; 31():240-243. PubMed ID: 30144654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human neuronal cells carrying ASTN2 deletion associated with psychiatric disorders.
    Hayashi Y; Okumura H; Arioka Y; Kushima I; Mori D; Lo T; Otgonbayar G; Kato H; Nawa Y; Kimura H; Aleksic B; Ozaki N
    Transl Psychiatry; 2024 Jun; 14(1):236. PubMed ID: 38830862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model.
    Murai K; Sun G; Ye P; Tian E; Yang S; Cui Q; Sun G; Trinh D; Sun O; Hong T; Wen Z; Kalkum M; Riggs AD; Song H; Ming GL; Shi Y
    Nat Commun; 2016 Mar; 7():10965. PubMed ID: 26965827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets.
    Manchia M; Piras IS; Huentelman MJ; Pinna F; Zai CC; Kennedy JL; Carpiniello B
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1054-1063. PubMed ID: 28732597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJSi001-A.
    Sun J; Zhang X; Cong Q; Wang C; Chen D; Wang Y; Wang X; Yi Z; Qin S
    Stem Cell Res; 2019 Jul; 38():101460. PubMed ID: 31102833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
    Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
    Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons.
    Habela CW; Song H; Ming GL
    Mol Cell Neurosci; 2016 Jun; 73():52-62. PubMed ID: 26655799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrotactin 2 (ASTN2) regulates emotional and cognitive functions by affecting neuronal morphogenesis and monoaminergic systems.
    Ito T; Yoshida M; Aida T; Kushima I; Hiramatsu Y; Ono M; Yoshimi A; Tanaka K; Ozaki N; Noda Y
    J Neurochem; 2023 Apr; 165(2):211-229. PubMed ID: 36807153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin.
    Ni P; Zhou C; Meng Y; Xue R; Yang X; Li L; Zhao L; Wei J; Ni R; Wang Y; Ma X; Guo W; Wang Q; Li T
    Stem Cell Res; 2022 Aug; 63():102832. PubMed ID: 35700633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of iPSCs from a patient with obsessive-compulsive disorder, his mother with schizophrenia and his healthy father.
    Yuan Yin X; Hua Zhu Z; Feng Chen R; Li J; Ya Zhang G; Long Hou W; Nan Zhuang N; Cai Y; Bin Dai N; Liu F; Wang J; Fang Jia Q; Hui L
    Stem Cell Res; 2023 Feb; 66():102993. PubMed ID: 36502622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF).
    Fidan K; Kavaklıoğlu G; Ebrahimi A; Özlü C; Ay NZ; Ruacan A; Gül A; Önder TT
    Stem Cell Res; 2015 Nov; 15(3):694-6. PubMed ID: 26987928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus Cells.
    Chang WF; Hwu YM; Xu J; Lin CJ; Wang SW; Cheng AS; Lu J; Lu CH; Sung LY
    PLoS One; 2016; 11(11):e0165715. PubMed ID: 27802323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of induced pluripotent stem cells from a patient with 16p13.11 duplication and VPS13B deletion.
    Okumura H; Arioka Y; Kushima I; Mori D; Ozaki N
    Stem Cell Res; 2022 Oct; 64():102884. PubMed ID: 35944312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells.
    Hoffmann A; Ziller M; Spengler D
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.